(Q44268815)

1 December 2017

BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han. (English)

1 reference

1 December 2017

Rui-Qun Qi

1

1 reference

1 December 2017

Li He

2

1 reference

1 December 2017

Song Zheng

3

1 reference

1 December 2017

Yuxiao Hong

4

1 reference

1 December 2017

Lei Ma

5

1 reference

1 December 2017

Shifa Zhang

6

1 reference

1 December 2017

Liping Zhao

7

1 reference

1 December 2017

Xinjian Guo

8

1 reference

1 December 2017

Yong Wang

9

1 reference

1 December 2017

Jiang-Yun Yu

10

1 reference

1 December 2017

Lan Fu

11

1 reference

1 December 2017

Wei Zhang

12

1 reference

1 December 2017

Tingfeng Long

13

1 reference

1 December 2017

Chao Zhang

14

1 reference

1 December 2017

Guohong Chen

15

1 reference

1 December 2017

Junping Lin

16

1 reference

1 December 2017

Chengliang Wang

17

1 reference

1 December 2017

Li Zhou

18

1 reference

1 December 2017

Qingsheng Mi

19

1 reference

1 December 2017

Matthew Weiland

20

1 reference

1 December 2017

John Z S Chen

21

1 reference

1 December 2017

S S Salum McHenga

22

1 reference

1 December 2017

Ya-Kun Wang

23

1 reference

1 December 2017

Uwesu McHepange

24

1 reference

1 December 2017

Zhimin Wang

25

1 reference

1 December 2017

Hong-Duo Chen

26

1 reference

1 December 2017

Xing-Hua Gao

27

1 reference

1 December 2017

language of work or name

English

0 references

publication date

17 February 2011

1 reference

Journal of Investigative Dermatology

1 December 2017

1 reference

1 December 2017

131

1 reference

1 December 2017

5

1 reference

1 December 2017

1129-1138

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2010.405

1 December 2017

0 references

cites work

Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Sunlight ultraviolet irradiation and BRAF V600 mutagenesis in human melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Braf(V600E) cooperates with Pten loss to induce metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Germline variation controls the architecture of somatic alterations in tumors

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

The MAPK pathway in melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Early detection of malignant melanoma: the role of physician examination and self-examination of the skin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Epidemiology of melanocytic nevi

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E mutational status and sustained extracellular signal-regulated kinase/mitogen-activated protein kinase pathway suppression.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Rapid screening of 4000 individuals for germ-line variations in the BRAF gene

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

BRAF mutations are common somatic events in melanocytic nevi.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

MC1R germline variants confer risk for BRAF-mutant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Determinants of BRAF mutations in primary melanomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

High frequency of BRAF mutations in nevi

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

BRAF and NRAS mutations in melanoma and melanocytic nevi

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

BRAF point mutations in primary melanoma show different prevalences by subtype.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Genetic alterations in melanocytic tumors

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.405

7 January 2021

Identifiers

DOI

10.1038/JID.2010.405

1 reference

Dimensions Publication ID

1 December 2017

0 references

1 reference